|
Compare
Acomplia Rimonabant
Prices Here
|
| Rimonabant & Smoking |
Smoking is one of the health hazardous vices that most of the
people have widely adopted in the world today. Smoking has believed
to be the major cause of various heart related diseases and various
types of cancer too. Quitting smoking is really very difficult
process but for the seriously intending persons Sanofi-Aventis has
designed and introduced the wonder medication called Rimonabant or
Accomplia.
Just about the couple of years back, some researchers impatiently
stated to the annual scientific meeting of the American College of
Cardiology that the new wonderful drug launched by Sanofi-Aventis
called Rimonabant or Accomplia has poised to simply double the
chances of giving up smoking habits while considerably diminishing
the weight gain that frequently go along with smoking cessation.
Dr. Robert Anthenelli of the University of Cincinnati – one of the
leading researchers during the presentation of study results
revealed by the company, declared that ‘this may be the most vital
step towards the smoking cessation therapy. Besides the trials
called STRATUS-STudies with Rimonabant And Tobacco USe that showed
the most peasant results and much more was further anticipated out
of a couple of additional smoking cessation trials called STRATUS-EU
and STRATUS-WW.
Rimonabant or Accomplia is the first new class of selective CB1
cannabinoid receptor blocker medication that is indicated for
helping the weight loss and anti-smoking therapies. The natural EC
system – endocannabinoid regulates the energy stability in addition
to the nicotine dependence of the body. Also the excessively
motivated endocannabinoid process is believed to be playing
essential role in obesity and the tobacco dependency.
|
|
